Location History:
- Cromwell, CT (US) (1992)
- Higganum, CT (US) (1990 - 1995)
Company Filing History:
9 out of 3,684 
1 out of 637 
1 out of 41 Years Active: 1990-1995
Title: **The Innovative Mind of Daniel R. Schroeder**
Introduction
Daniel R. Schroeder is a notable inventor based in Higganum, Connecticut, whose contributions to science and medicine have been recognized through his eleven patents. His work primarily focuses on the development of novel therapeutic compounds with significant antitumor properties, reflecting his commitment to advancing biomedical research.
Latest Patents
Among his latest innovations are two significant patents. The first is related to **Rebeccamycin analogs by tryptophan analogs feeding**, where the addition of specific tryptophan analogs during the fermentation process of a rebeccamycin-producing strain of Saccharothrix aerocolonigenes leads to the creation of new rebeccamycin analogs. These new compounds are noted for their advantageous antitumor properties. His second recent patent covers an **antitumor antibiotic** derived from a fermentation product of Actinomadura strain Q473-8, which, when appropriately treated, yields a novel compound exhibiting both antibiotic and antitumor activities.
Career Highlights
Daniel has had a distinguished career with significant roles in reputable companies such as Bristol-Myers Squibb Company and Bristol-Myers Company. His tenure at these organizations not only honed his skills as an inventor but also allowed him to contribute to vital research initiatives in the pharmaceutical industry.
Collaborations
Throughout his career, Daniel has collaborated with talented individuals in the field. Among his notable coworkers are Kin S. Lam and Jacqueline M. Mattei. Their collective efforts in research and development underscore the importance of teamwork in driving innovation and achieving common goals in inventiveness.
Conclusion
Daniel R. Schroeder stands out as an influential inventor whose patents reflect a deep understanding of biochemistry and a drive to develop new therapeutic solutions. His latest innovations in antitumor antibiotics and related compounds highlight the potential for advancements in medical treatment, showcasing his legacy in the field of inventiveness.